Authors


Michael McDermott, PharmD

Latest:

The Role of Daridorexant in the Treatment of Insomnia

Although pharmacotherapy is considered for the treatment of insomnia, medication should not be the sole treatment for individuals diagnosed with insomnia.


Alana Hippensteele, Managing Editor

Latest:

Current Trends, Treatment Strategies for C diff Infection

Paul Feuerstadt, MD, FACG, AGAF, discusses insights in current treatment practices for CDI at the Peggy Lillis Foundation’s 2023 State of C diff Virtual Town Hall.


Anne Lin, PharmD, BCPS

Latest:

Ousting the Pain: Migraine in University Students

Students may be hesitant to discuss migraines, which can lead to absences, difficulties in personal life, financial burdens, and poor mental health.


Morgan Anderson, PharmD, BCIDP

Latest:

Shorter Course of Treatment for CAP in Children Demonstrates Success

Pediatric guidelines suggest 10 days of therapy for community-acquired pneumonia, but recent data support shortening therapy duration.


Maria K. Shockley, BS

Latest:

How Does the EUA for the COVID-19 Vaccines Work?

FDA approvals of vaccines usually take 10 to 15 years, but the pandemic necessitates emergency action.


Cori Hawkins, PharmD

Latest:

Supporting Medication Adherence With Motivational Interviewing

Motivational Interviewing is a collaborative conversation style that can empower patients to stay the course and achieve better outcomes.


Ashley R. Walker, PharmD

Latest:

Pharmacy Schools Can Break Down Barriers Between Pharmacists, Deaf Community

Most pharmacists and technicians are unaware of resources that aid in communication.


Amy H. Seung, PharmD, BCOP, FHOPA, CHCP

Latest:

Oncology Pharmacists Bring Value and Contribute to Cancer Care

Oncology pharmacists are as diverse as the cancers they manage and have key roles in the following areas of the cancer care continuum.


Biao He, PhD

Latest:

From Setbacks to Solutions: Pioneering Safe RSV Vaccines for Infants, Children

With respiratory syncytial virus vaccine development for infants and children proceeding slowly, therapeutic developers have focused on passive immunity


Lee Ann Waldron

Latest:

The Challenges in Launching Alaska's First Pharmacy School

A shortage of pharmacists led to a call for pharmacy education in Alaska that echoed across the state.


Amruta Chowgule

Latest:

Regional Trends Reinforcing Breast Cancer Therapeutics Market

Over the next few years, undiagnosed breast cancer cases may add to the demand for more rigorous end-stage treatments and therapeutics.


David Gortler, PharmD, FCCP

Latest:

How the White House's New FDA Commissioner Caused the Baby Formula Crisis

The FDA's current way of inspecting facilities for quality control is badly outdated and is politically unworkable, unreliable, and unsafe.


Christopher Epps, PharmD Candidate

Latest:

Case Studies: June 2022

How would you respond to these patients questions?


Lauren Stonerock, PharmD

Latest:

As Easy as ABE: A Pharmacist’s Overview of Updates to the COPD GOLD Guidelines

Data show that dose-response relationships and long-term safety of ICS in people with chronic obstructive pulmonary disease are unclear and require further investigation.



Herman W. Powery II, PharmD, BCOP

Latest:

Current Drug Pathways in Non–Small Cell Lung Cancer

Advancements in genomic and mutational analysis show that up to 60% of adenocarcinomas and up to 50% to 80% of squamous cell carcinomas (SCC) have a known oncogenic driver mutation.


Bani Tamraz, PharmD, PhD

Latest:

How 2023 Can Be the Year of Clinical Pharmacogenomics

In terms of science and technology, the health care community has everything needed to clinically implement pharmacogenomics testing.


Nabila Ismail, PharmD

Latest:

Dengue Vaccine: What Pharmacists Need to Know

The FDA approved the first vaccine for dengue disease in May 2019.


Syuleyman Bektashev

Latest:

Interactive Case Studies: January 2022

How would you respond to these patients' questions?


Bob Zutaut, RPh

Latest:

Pharmacy Can Help Drive Adoption of Rheumatoid Arthritis Biosimilars

Pharmacists will have the opportunity to use their knowledge of biosimilars to reinforce their benefits, safety, and efficacy.


Mindy Smith, BSPharm, RPh, MHA, CMWA

Latest:

Driving Patient Safety With New Pharmacy HIT Standards

New standards from the National Council for Prescription Drug Programs could drive changes that improve patient safety by optimizing drug therapy to reduce the risk of harm and improve health and well-being before a medication is dispensed.


Carissa Treptow, PharmD, BCOP

Latest:

Multiple Myeloma Therapy Often Causes Cardiovascular Complications

Many patients have baseline risk factors present at diagnosis because of older age and disease-related elements.


Rachel Marini, PharmD

Latest:

Recognize the Value of Health Care Volunteers

The health care industry must cultivate volunteer support to maintain a positive impact on vaccination rates.


Advit Shah, BSc, BSc Pharmacy, RPh

Latest:

How to Create an Inclusive Culture for LGBTQ+ Patients at the Pharmacy: A Practical Approach

Facilitating environmental cues that members of the LGBTQ+ community look for to signify that they are in a safe space is an especially important element for the LGBTQ+ community.


Cameron Abbey-Mott, PharmD

Latest:

Clinical Overview: Dapagliflozin for Patients with Heart Failure, Reduced Ejection Fraction and Preserved Ejection Fraction

Management of heart failure focuses on avoiding reversible precipitants and optimizing guideline-directed therapy to lower mortality and hospitalizations.


Carl V. Crawford, MD

Latest:

Looking Toward the Future of CDI Management

Closing out their discussion on Clostridioides difficile infection, panelists share closing thoughts on novel pipeline therapies.


Nishant Thakar, PharmD; Ibraheem Rajab, Bchem; and Sinni Moozhayil, BPharm, MS

Latest:

Extemporaneous Compounding of Amoxicillin Suspensions During National Shortage

As of November 2022, amoxicillin suspension has been on a national shortage list, therefore the FDA has permitted temporary compounding of amoxicillin suspensions.


Nithya Srinivasan, Director of Marketing, Rheumatology, Janssen Immunology

Latest:

Holistic Psoriatic Arthritis Care: Why Well-Being Should Be Incorporated Into the Treatment Paradigm

People living with psoriatic arthritis deserve to be informed about ways to approach disease management holistically and with a personalized approach.


Doug Field

Latest:

Pharmacies Poised to Capture At-Home Diagnostics Category

By leveraging do-it-yourself testing momentum, community-based and retail pharmacies can solidify their position as health care hubs with a category management approach that enhances the consumer experience and boosts store relevance and revenue.


Abigail Johnson

Latest:

Study Highlights Pharmacy Student Perspective on Mental Health, Future Practice

Pharmacy programs are implementing new practices into their curriculum and research is being focused on mental health care.

© 2023 MJH Life Sciences

All rights reserved.